Similar articles

• [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung].

  Sanz Ortiz J, Saiz García F. Sanz Ortiz J, et al. Med Clin (Barc). 1982 Nov 16-30;79(9):403-6. Med Clin (Barc). 1982. PMID: 6296560 Clinical Trial. Spanish. No abstract available.
• cis-Dichlorodiammineplatinum(II), adriamycin, cyclophosphamide, CCNU, and vincristine in non-small cell lung carcinoma: a preliminary report.

  Takita H, Marabella PC, Edgerton F, Rizzo D. Takita H, et al. Cancer Treat Rep. 1979 Jan;63(1):29-33. Cancer Treat Rep. 1979. PMID: 369692 Clinical Trial. No abstract available.
• Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.

  Bitran JD, Desser RK, DeMeester TR, Colman M, Evans R, Billings A, Griem M, Rubenstein L, Shapiro C, Golomb HM. Bitran JD, et al. Cancer Treat Rep. 1976 Sep;60(9):1225-30. Cancer Treat Rep. 1976. PMID: 189920
• The treatment of lung cancer.

  Zubrod CG, Selawry O. Zubrod CG, et al. Adv Intern Med. 1978;23:451-67. Adv Intern Med. 1978. PMID: 204171 Review. No abstract available.
• The role of chemotherapy in the treatment of lung cancer.

  Selawry OS. Selawry OS. Semin Oncol. 1974 Sep;1(3):259-72. Semin Oncol. 1974. PMID: 4143488 Review. No abstract available.